Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 5, Number 2—April 1999
Dispatch

Evaluating Diagnosis and Treatment of Oral and Esophageal Candidiasis in Ugandan AIDS Patients

Maurizio Ravera, Alberto Reggiori, Anna Maria Agliata, and Roberto Pidoto Rocco
Author affiliations: Regional Teaching Hospital, Hoima, Uganda

Main Article

Table

Characteristics of patients participat- ing in the study

No. Mean age
(yr) (S.D.) Sex
M/F
Oral candidiasis 85 24.0 (6.7) 32 / 53
Esophageal symptomsa 40 17 / 23
Nystatin group 20 23.9 (6.1) 7 / 13
Miconazole group 20 23.7 (6.6) 8 / 12
Esophageal candidiasis 77 23.7 (6.4) 27 / 50
Nystatin group 37 24.2 (6.5) 12 / 22
Miconazole group 40 23.4 (6.1) 15 / 28

aEsophageal symptoms are any of the following: odinophagia, dysphagia, retrosternal burning pain.

Main Article

Page created: December 10, 2010
Page updated: December 10, 2010
Page reviewed: December 10, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external